FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients

BACKGROUND: Epithelial ovarian cancer (EOC) is a spectrum of different diseases, which makes their treatment a challenge. Forkhead box M1 (FOXM1) is an oncogene aberrantly expressed in many solid cancers including serous EOC, but its role in non-serous EOCs remains undefined. We examined FOXM1 expre...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Exp Clin Cancer Res
Auteurs principaux: Tassi, Renata A., Todeschini, Paola, Siegel, Eric R., Calza, Stefano, Cappella, Paolo, Ardighieri, Laura, Cadei, Moris, Bugatti, Mattia, Romani, Chiara, Bandiera, Elisabetta, Zanotti, Laura, Tassone, Laura, Guarino, Donatella, Santonocito, Concetta, Capoluongo, Ettore D., Beltrame, Luca, Erba, Eugenio, Marchini, Sergio, D’Incalci, Maurizio, Donzelli, Carla, Santin, Alessandro D., Pecorelli, Sergio, Sartori, Enrico, Bignotti, Eliana, Odicino, Franco, Ravaggi, Antonella
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2017
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5422964/
https://ncbi.nlm.nih.gov/pubmed/28482906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-017-0536-y
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires